Macugen

In the US, Macugen (pegaptanib ophthalmic) is a member of the drug class anti-angiogenic ophthalmic agents and is used to treat Macular Degeneration.

US matches:

UK matches:

Ingredient matches for Macugen

Pegaptanib

Pegaptanib is reported as an ingredient of Macugen in the following countries:

  • Iceland
  • Italy
  • Slovenia
  • Spain

Pegaptanib octasodium (a derivative of Pegaptanib) is reported as an ingredient of Macugen in the following countries:

  • Austria
  • Belgium
  • Canada
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Ireland
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Mexico
  • Netherlands
  • Peru
  • Philippines
  • Portugal
  • Romania
  • Singapore
  • Slovakia
  • Sweden
  • Switzerland
  • Thailand
  • Turkey
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)